Owens & Minor, Inc. (OMI)
NYSE: OMI · IEX Real-Time Price · USD
13.24
+0.22 (1.69%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Owens & Minor Revenue

Owens & Minor had revenue of $10.42B in the twelve months ending March 31, 2024, with 3.50% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.61B with 3.56% year-over-year growth. In the year 2023, Owens & Minor had annual revenue of $10.33B with 3.80% growth.

Revenue (ttm)
$10.42B
Revenue Growth
+3.50%
P/S Ratio
0.10
Revenue / Employee
$469,540
Employees
22,200
Market Cap
1.01B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202310.33B378.49M3.80%
Dec 31, 20229.96B170.16M1.74%
Dec 31, 20219.79B1.31B15.39%
Dec 31, 20208.48B-730.76M-7.93%
Dec 31, 20199.21B-207.25M-2.20%
Dec 31, 20189.42B99.92M1.07%
Dec 31, 20179.32B-405.16M-4.17%
Dec 31, 20169.72B-49.52M-0.51%
Dec 31, 20159.77B332.76M3.52%
Dec 31, 20149.44B368.65M4.06%
Dec 31, 20139.07B203.21M2.29%
Dec 31, 20128.87B240.41M2.79%
Dec 31, 20118.63B504.30M6.21%
Dec 31, 20108.12B85.98M1.07%
Dec 31, 20098.04B794.39M10.97%
Dec 31, 20087.24B548.64M8.20%
Dec 31, 20076.69B1.25B23.03%
Dec 31, 20065.44B618.85M12.83%
Dec 31, 20054.82B297.31M6.57%
Dec 31, 20044.53B281.04M6.62%
Dec 31, 20034.24B284.29M7.18%
Dec 31, 20023.96B144.79M3.80%
Dec 31, 20013.81B311.41M8.89%
Dec 31, 20003.50B309.45M9.69%
Dec 31, 19993.19B104.09M3.37%
Dec 31, 19983.09B-26.75M-0.86%
Dec 31, 19973.12B97.80M3.24%
Dec 31, 19963.02B42.52M1.43%
Dec 31, 19952.98B580.68M24.24%
Dec 31, 19942.40B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ironwood Pharmaceuticals 413.55M
MiMedx Group 334.51M
Innoviva 311.59M
Gyre Therapeutics 140.62M
BioLife Solutions 137.30M
Ocular Therapeutix 59.84M
Tango Therapeutics 37.23M
Autolus Therapeutics 10.50M
Revenue Rankings